Matches in Wikidata for { <http://www.wikidata.org/entity/Q91568036> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q91568036 description "article scientifique publié en 2019" @default.
- Q91568036 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91568036 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91568036 description "scientific article published on 25 April 2019" @default.
- Q91568036 description "wetenschappelijk artikel" @default.
- Q91568036 description "наукова стаття, опублікована 25 квітня 2019" @default.
- Q91568036 name "Long term treatment with quercetin in contrast to the sulfate and glucuronide conjugates affects HIF1α stability and Nrf2 signaling in endothelial cells and leads to changes in glucose metabolism" @default.
- Q91568036 name "Long term treatment with quercetin in contrast to the sulfate and glucuronide conjugates affects HIF1α stability and Nrf2 signaling in endothelial cells and leads to changes in glucose metabolism" @default.
- Q91568036 type Item @default.
- Q91568036 label "Long term treatment with quercetin in contrast to the sulfate and glucuronide conjugates affects HIF1α stability and Nrf2 signaling in endothelial cells and leads to changes in glucose metabolism" @default.
- Q91568036 label "Long term treatment with quercetin in contrast to the sulfate and glucuronide conjugates affects HIF1α stability and Nrf2 signaling in endothelial cells and leads to changes in glucose metabolism" @default.
- Q91568036 prefLabel "Long term treatment with quercetin in contrast to the sulfate and glucuronide conjugates affects HIF1α stability and Nrf2 signaling in endothelial cells and leads to changes in glucose metabolism" @default.
- Q91568036 prefLabel "Long term treatment with quercetin in contrast to the sulfate and glucuronide conjugates affects HIF1α stability and Nrf2 signaling in endothelial cells and leads to changes in glucose metabolism" @default.
- Q91568036 P1433 Q91568036-D0C95A3F-7D28-47E3-BCD6-EFE90F54760D @default.
- Q91568036 P1476 Q91568036-C75C415C-59C8-4ED0-9EDD-85EE0A4ADD55 @default.
- Q91568036 P2093 Q91568036-12C7E923-AC4C-4735-BB30-7BCCBB5CB658 @default.
- Q91568036 P2093 Q91568036-672A99E7-48DB-405D-838A-CF0AB70BDDCD @default.
- Q91568036 P304 Q91568036-D5570539-CD7B-49E9-8B8C-4EC76E6D809E @default.
- Q91568036 P31 Q91568036-42E26A5D-B21B-410F-8598-EB9A428B674F @default.
- Q91568036 P356 Q91568036-E617BF38-FBE4-4BB4-A8B5-87026266ED2A @default.
- Q91568036 P478 Q91568036-A44E3BC7-EEAF-48E2-907C-AC7603A02FA9 @default.
- Q91568036 P50 Q91568036-7F31B44B-2BE4-4FDF-931E-C364FB188458 @default.
- Q91568036 P577 Q91568036-39782B74-7544-4DBB-9C3D-9EFEB32F6F36 @default.
- Q91568036 P698 Q91568036-89289EC5-8C1F-4FEF-A269-3AD0014CC4A1 @default.
- Q91568036 P356 J.FREERADBIOMED.2019.04.023 @default.
- Q91568036 P698 31029788 @default.
- Q91568036 P1433 Q5500023 @default.
- Q91568036 P1476 "Long term treatment with quercetin in contrast to the sulfate and glucuronide conjugates affects HIF1α stability and Nrf2 signaling in endothelial cells and leads to changes in glucose metabolism" @default.
- Q91568036 P2093 "Asimina Kerimi" @default.
- Q91568036 P2093 "Gary Williamson" @default.
- Q91568036 P304 "158-168" @default.
- Q91568036 P31 Q13442814 @default.
- Q91568036 P356 "10.1016/J.FREERADBIOMED.2019.04.023" @default.
- Q91568036 P478 "137" @default.
- Q91568036 P50 Q84530429 @default.
- Q91568036 P577 "2019-04-25T00:00:00Z" @default.
- Q91568036 P698 "31029788" @default.